BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND OMD, osteoadherin, 4958, ENSG00000127083, Q99983, SLRR2C
22 results:

  • 1. Active involvement of patients, radiation oncologists, and surgeons in a multidisciplinary team approach: Guiding local therapy in recurrent, metastatic rectal cancer.
    Choi SH; Yang G; Koom WS; Yang SY; Kim SS; Lim JS; Kim HS; Shin SJ; Chang JS
    Cancer Med; 2023 Nov; 12(22):21057-21067. PubMed ID: 37909227
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study.
    Ottaiano A; De Luca A; Santorsola M; Scognamiglio G; Di Mauro A; Chiodini P; Lambiase M; Sacco A; Petrillo A; Granata V; Fusco R; Mercadante E; Martucci N; De Luca G; Rocca A; Celentano E; Crispo A; Di Gennaro P; Tatangelo F; Ferrara G; Izzo F; Belli A; Patrone R; Delrio P; Rega D; De Franciscis S; Muto P; Ravo V; Di Franco R; Borzillo V; Santagata S; Rea G; Castaldo D; Pace U; De Feo G; Scala S; Nasti G; Normanno N
    BMC Cancer; 2023 Oct; 23(1):1010. PubMed ID: 37858132
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Differential Perspectives by Specialty on Oligometastatic colorectal cancer: A Korean Oligometastasis Working Group's Comparative Survey Study.
    Cho WK; Yoo GS; Rim CH; Jeong JU; Chie EK; Ahn YC; Cho HM; Um JW; Suh YG; Chang AR; Lee JH;
    Cancer Res Treat; 2023 Oct; 55(4):1281-1290. PubMed ID: 37290481
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The management of oligometastatic disease in colorectal cancer: Present strategies and future perspectives.
    Carconi C; Cerreti M; Roberto M; Arrivi G; D'Ambrosio G; De Felice F; Di Civita MA; Iafrate F; Lucatelli P; Magliocca FM; Picchetto A; Picone V; Catalano C; Cortesi E; Tombolini V; Mazzuca F; Tomao S
    Crit Rev Oncol Hematol; 2023 Jun; 186():103990. PubMed ID: 37061075
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part I: non-small cell lung cancer and breast cancer.
    Rodríguez Pérez A; Felip Font E; Chicas-Sett R; Montero-Luis Á; de Paz Arias L; González-Del-Alba A; López-Campos F; López López C; Hernando Requejo O; Conde-Moreno AJ; Arranz Arija JÁ; de Castro Carpeño J
    Clin Transl Oncol; 2023 Apr; 25(4):882-896. PubMed ID: 36525231
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Unravelling oligometastatic disease from the perspective of radiation and medical oncology. Part II: prostate cancer and colorectal cancer.
    Conde-Moreno AJ; González-Del-Alba A; López-Campos F; López López C; Requejo OH; de Castro Carpeño J; Chicas-Sett R; de Paz Arias L; Montero-Luis Á; Pérez AR; Font EF; Arija JÁA
    Clin Transl Oncol; 2023 Apr; 25(4):897-911. PubMed ID: 36525230
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The pattern and treatment outcomes for rectal cancer with concurrent locoregional recurrence and distant metastases after total mesorectal excision.
    Chen Y; Li Y; Mo S; Hu X; Liu F; Cai S; Ma X; Peng J
    BMC Cancer; 2022 Oct; 22(1):1088. PubMed ID: 36280830
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Stereotactic body radiation therapy for metastatic lung metastases.
    Kimura T; Fujiwara T; Kameoka T; Adachi Y; Kariya S
    Jpn J Radiol; 2022 Oct; 40(10):995-1005. PubMed ID: 36097233
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
    Stefanovic M; Calvet G; Pérez-Montero H; Esteve A; Bujalance MV; Navarro-Martín A; Fernández MDA; González FF; Borras SM; Borbalas AL; Fernandez MN; Garau MM; Calduch AL; Edo FG
    Clin Transl Oncol; 2023 Jan; 25(1):199-206. PubMed ID: 36068449
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Automated Computer-Aided Detection of Lung Nodules in Metastatic colorectal cancer Patients for the Identification of Pulmonary Oligometastatic Disease.
    Lee JJB; Suh YJ; Oh C; Lee BM; Kim JS; Chang Y; Jeon YJ; Kim JY; Park SY; Chang JS
    Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):1045-1052. PubMed ID: 36028066
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The decreased platelet-to-lymphocyte ratio could predict a good prognosis in patients with oligometastatic colorectal cancer: a single-center cohort retrospective study.
    Huang X; Cui J; Li X; Liu C; Sun J; Yue J
    World J Surg Oncol; 2021 Oct; 19(1):297. PubMed ID: 34645481
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Late metastatic presentation is associated with improved survival and delayed wide-spread progression after ablative stereotactic body radiotherapy for oligometastasis.
    Chen X; Chen H; Poon I; Erler D; Badellino S; Biswas T; Dagan R; Foote M; Louie AV; Ricardi U; Sahgal A; Redmond KJ
    Cancer Med; 2021 Sep; 10(18):6189-6198. PubMed ID: 34432390
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Impact of EndoRings on colon adenoma detection rate: A meta-analysis of randomized trials.
    Facciorusso A; Mohan BP; Crinò SF; Muscatiello N
    J Gastroenterol Hepatol; 2021 Feb; 36(2):337-343. PubMed ID: 33140884
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Oligometastatic colorectal cancer: prognosis, role of locoregional treatments and impact of first-line chemotherapy-a pooled analysis of TRIBE and TRIBE2 studies by Gruppo Oncologico del Nord Ovest.
    Moretto R; Rossini D; Zucchelli G; Lonardi S; Bergamo F; Santini D; Cupini S; Tomasello G; Caponnetto S; Zaniboni A; Antoniotti C; Pietrantonio F; Buonadonna A; Marmorino F; Bordonaro R; Fea E; Tamburini E; Boccaccino A; Grande R; Aprile G; Falcone A; Cremolini C
    Eur J Cancer; 2020 Nov; 139():81-89. PubMed ID: 32979645
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Oligometastatic colorectal cancer Management: A Survey of the Italian College of Interventional Radiology.
    Calandri M; Gazzera C; Giurazza F; Yevich S; Strazzarino GA; Brino J; Marra P; Contegiacomo A; Bargellini I; Cariati M; Fonio P; Veltri A
    Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1474-1483. PubMed ID: 32449016
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
    Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
    Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Tailoring ablation strategies for colorectal liver metastases based upon rat sarcoma viral oncogene mutation status.
    Calandri M; Odisio BC
    Chin Clin Oncol; 2019 Oct; 8(5):51. PubMed ID: 31500432
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Local treatment of oligometastatic disease: current role.
    Winkelmann MT; Clasen S; Pereira PL; Hoffmann R
    Br J Radiol; 2019 Aug; 92(1100):20180835. PubMed ID: 31124700
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A risk-based approach to identifying oligometastatic disease on imaging.
    deSouza NM; Tempany CM
    Int J Cancer; 2019 Feb; 144(3):422-430. PubMed ID: 30098215
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Microwave Ablation for Lung Neoplasms: A Retrospective Analysis of Long-Term Results.
    Healey TT; March BT; Baird G; Dupuy DE
    J Vasc Interv Radiol; 2017 Feb; 28(2):206-211. PubMed ID: 27993505
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 2.